To join this class action, please complete the following Investor Certification.  [contact-form-7 id=”896″ title=”OPKO Health, Inc. Investor Certification”] Oklahoma City, OK (September 18, 2018) – On September 12, 2018, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against OPKO Health, Inc. (NASDAQ: OPK).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price […]

To join this class action, click here to obtain an Investor Certification.  Once completed, please email this form to rkh@federmanlaw.com, fax to us at (405) 239-2112 or send by regular mail to Federman & Sherwood, 10205 North Pennsylvania Avenue, Oklahoma City, OK  73120 ATTN:  Robin.  On September 11, 2018, a securities class action lawsuit was filed in the United States District Court for the District of New Jersey against USA Technologies, Inc. (NASDAQ: USAT).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing […]

To:  All persons and/or entities who purchased common stock in Juno Therapeutics, Inc.  [NASDAQ: JUNO] during the period from  June 4, 2016 To November 22, 2016 , and were damaged thereby; a settlement has been announced in the securities litigation known as In re Juno Therapeutics, Inc., No. C16-1069-RSM , United States District Court for the Western District of Washington.  For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is November […]

To:  All persons and/or entities who purchased common stock in Medtronic, Inc. [NYSE: MDT] during the period from  September 8, 2010, through and including June 28, 2011, and were damaged thereby; a settlement has been announced in the securities litigation known as  In re Medtronic, Inc. Securities Litigation, Civil Action No.  0:13-cv-01686-MJD-KMM, in the United States District Court for the  District Of Minnesota.  For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission […]

Oklahoma City, OK (August 16, 2018) – The law firm of Federman & Sherwood has initiated an investigation into Blink Charging Co. (“Blink”) and its officers and directors, with respect to possible violations of federal securities laws. Blink Charging Co. is one of the leaders in nationwide public electric vehicle (EV) charging equipment and services, enabling EV drivers to easily charge at locations throughout the United States.  Headquartered in Florida with offices in Arizona and California, Blink’s business is designed to accelerate EV adoption.  Federman & Sherwood is investigating possible breaches of fiduciary duty. If you have any information to […]

The law firm of Federman & Sherwood has initiated an investigation into Wells Fargo & Company [NYSE:  WFC] with respect to claims related to mortgage loan modifications and wrongful foreclosures between April 13, 2010 and October 20, 2015.  If you had a mortgage through WFC and were denied a loan modification or were not offered a modification, were foreclosed or have information to assist in our investigation; or, have any questions or concerns regarding this notice or preservation of your rights, please contact Robin Hester at rkh@federmanlaw.com.  Federman & Sherwood has extensive nationwide experience in representing mortgagees, investors in securities, […]

To join this class action, please complete the following Investor Certification.    On August 9, 2018, a securities class action lawsuit was filed in the United States District Court for the Northern District of Texas against Zion Oil & Gas, Inc. (NASDAQ: ZN).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is March 12, 2018 through July […]

To join this class action, please complete the following Investor Certification.    Oklahoma City, OK (August 3, 2018) – On August 2, 2018, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against Helios and Matheson Analytics, Inc. (NASDAQ: HMNY).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class […]

To join this class action, please complete the following Investor Certification.    Oklahoma City, OK (July 30, 2018) – On July 27, 2018, a securities class action lawsuit was filed in the United States District Court for the Eastern District of New York against Rockwell Medical, Inc. (NASDAQ: RMTI).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which […]

To join this class action, please complete the following Investor Certification.    Oklahoma City, OK (July 25, 2018) – On July 19, 2018, a securities class action lawsuit was filed in the United States District Court for the Southern District of California against Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is […]